The main issues with the TPP are the limitations in chapters 8 and 25 on the ability of the Canadian government to intervene to set regulations controlling the price of drugs; the ability for investors to sue the federal government more widely; the failure to exempt health care clearly; and the intellectual property provisions.
What's clear to health care advocates is that Canada does not need the TPP, but what we do need is a national, universal, comprehensive drug program for all Canadians.
Thank you.